RTTNews | Dec 1, 2020 07:10AM EST

07:10 Tuesday, December 1, 2020 (RTTNews) - REGENXBIO Reports Dosing Of First Patient In Phase I/II Trial Of RGX-111 For Mucopolysaccharidosis Type I

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved